Donald W. Lamoureaux, M.D.; Decision and Order, 8434-8435 [2017-01688]
Download as PDF
8434
Federal Register / Vol. 82, No. 15 / Wednesday, January 25, 2017 / Notices
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
September 14, 2016, Organix, Inc., 240
Salem Street, Woburn, Massachusetts
01801, applied to be registered as a bulk
manufacturer of the following basic
classes controlled substances:
Controlled substance
Gamma Hydroxybutyric
Acid.
Lysergic acid
diethylamide.
Marihuana .....................
Tetrahydrocannabinols
Psilocybin ......................
Psilocyn ........................
Heroin ...........................
Morphine .......................
Drug
code
Schedule
2010
I
7315
I
7360
7370
7437
7438
9200
9300
I
I
I
I
I
II
The company plans to manufacture
reference standards for distribution to
its research and forensics customers. In
reference to drug code 7360 (marihuana)
and 7370 (THC) the company plans to
manufacture these drugs as synthetic.
No other activities for these drug codes
are authorized for this registration.
Dated: December 22, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2017–01582 Filed 1–24–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
mstockstill on DSK3G9T082PROD with NOTICES
Donald W. Lamoureaux, M.D.; Decision
and Order
On September 16, 2016, the Assistant
Administrator, Division of Diversion
Control, Drug Enforcement
Administration (DEA), issued an Order
to Show Cause to Donald W.
Lamoureaux, M.D. (Registrant), of
Horseshoe Bend, Arkansas. The Show
Cause Order proposed the revocation of
his DEA Certificate of Registration,
pursuant to which he is authorized to
dispense controlled substances in
schedules II through V, as a practitioner,
on the ground that he ‘‘do[es] not have
authority to handle controlled
substances in Arkansas, the [S]tate in
which he is registered with the DEA.’’
Show Cause Order, at 1.
As grounds for the proceeding, the
Show Cause Order alleged that
Registrant is registered with the DEA as
a practitioner authorized to dispense
controlled substances in schedules II
through V, pursuant to Certificate of
VerDate Sep<11>2014
20:29 Jan 24, 2017
Jkt 241001
Registration No. FL2413297, at the
registered address of 707 Third Street,
Horseshoe Bend, Arkansas. Id. The
Order also alleged that his registration
does not expire until March 31, 2017.
Id.
The Show Cause Order then alleged
that Registrant’s Arkansas medical
license expired on April 30, 2015, and
that he is currently without authority to
dispense controlled substances in
Arkansas, the State in which he is
registered with the DEA. Id. at 1–2.
Based upon Registrant’s lack of
authority to handle controlled
substances in the State of Arkansas, the
Government asserts that his registration
is subject to revocation. Id. at 2 (citing
21 U.S.C. §§ 802(21), 823(f) and
824(a)(3)).
The Show Cause Order also notified
Registrant of his right to request a
hearing on the allegations or to submit
a written statement in lieu of a hearing,
the procedures for electing either
option, and the consequence for failing
to elect either option. Id. at 2 (citing 21
CFR 1301.43). In addition, the Order
notified Registrant of his right to submit
a Corrective Action Plan. Id. at 2–3.
On September 19, 2016, the Show
Cause Order was sent via certified mail
to Registrant at his current residence,
the Federal Correctional Institution,
Butner, North Carolina, 27509.
Government Request for Final Agency
Action (RFAA), Appendix 4,
Declaration, at 1. As evidenced by a
copy of the signed return receipt card,
service was accomplished on September
22, 2016. Id.; See also Appendix 4, at 3–
4.
On November 1, 2016, the
Government forwarded to my Office a
Request for Final Agency Action and an
evidentiary record. In its Request, the
Government represents that it has not
received a request for a hearing or any
other reply from Registrant. RFAA, at 2.
The Government thus seeks the
revocation of Registrant’s Registration
on the ground that he lacks state
authority. Id. at 4.
Based upon the Government’s
representation and the record, I find that
more than 30 days have now passed
since the date of service of the Show
Cause Order, and neither Registrant, nor
anyone purporting to represent him, has
requested a hearing or submitted a
written statement in lieu of a hearing. I
therefore find that Registrant has waived
his right to a hearing or to submit a
written statement in lieu of a hearing
and issue this Decision and Final Order
based on relevant evidence contained in
the record submitted by the
Government. 21 CFR 1301.43(d) & (e). I
make the following findings of fact.
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Findings
Respondent is the holder of
practitioner’s registration FL2413297,
pursuant to which he is authorized to
dispense controlled substances in
schedules II through V at the registered
address of 707 Third Street, Horseshoe
Bend, Arkansas; this registration does
not expire until March 31, 2017.
Declaration of the Diversion Investigator
(DI), at 1. According to the DI,
Registrant’s license to practice medicine
in Arkansas lapsed on April 30, 2015,
and he currently has no authority to
practice medicine in that State. Id. at 1.
As further support for the action, the
DI obtained, and the Government
submitted, a license verification from
the Arkansas State Medical Board along
with a Certification from the Board’s
Executive Secretary that the license
verification was true and correct as of
September 15, 2016. Appendix 2, at 1;
Appendix 3, at 1. This document shows
that as of September 14, 2016, the Board
listed the expiration date of Registrant’s
medical license as ‘‘April 30, 2015’’ and
the status of his license as ‘‘Inactive’’; it
also includes the notation: ‘‘License
Category: Felony Conviction.’’
Appendix 3, at 2. Also, the document
contains the following Board History
notes, which include that:
1. On February 9, 2015, the Board issued
an Emergency Order of Suspension to
Registrant;
2. On April 10, 2015, the Board voted ‘‘to
continue the disciplinary hearing until after
[Registrant’s] [] trial date’’;
3. On July 2, 2015, the Board voted ‘‘to
block [Registrant’s] access to renew his
license should he wish to renew’’; and
4. On December 3, 2015, Registrant’s
‘‘medical license lapsed subsequent to the
felony criminal conviction.’’
Appendix 3, at 4–5. As Registrant did
not respond to the Show Cause Order,
let alone submit any evidence to show
that his state license has been
reinstated, I find that he does not
possess authority to dispense controlled
substances under the laws of Arkansas,
the State in which he is registered with
the Agency.
Discussion
Pursuant to 21 U.S.C. 824(a)(3), the
Attorney General is authorized to
suspend or revoke a registration issued
under section 823 of Title 21, ‘‘upon a
finding that the registrant . . . has had
his State license . . . suspended [or]
revoked . . . by competent State
authority and is no longer authorized by
State law to engage in the . . .
dispensing of controlled substances.’’
With respect to a practitioner, DEA has
repeatedly held that the possession of
authority to dispense controlled
E:\FR\FM\25JAN1.SGM
25JAN1
Federal Register / Vol. 82, No. 15 / Wednesday, January 25, 2017 / Notices
mstockstill on DSK3G9T082PROD with NOTICES
substances under the laws of the State
in which he engages in professional
practice is a fundamental condition for
obtaining and maintaining a
registration. See, e.g., James L. Hooper,
76 FR 71371 (2011), pet. for rev. denied,
481 Fed Appx. 826 (4th Cir. 2012); see
also Frederick Marsh Blanton, 43 FR
27616 (1978) (‘‘State authorization to
dispense or otherwise handle controlled
substances is a prerequisite to the
issuance and maintenance of a Federal
controlled substances registration.’’).
This rule derives from the text of two
provisions of the CSA. First, Congress
defined ‘‘the term ‘practitioner’ [to]
mean[] a . . . physician . . . or other
person licensed, registered, or otherwise
permitted, by . . . the jurisdiction in
which he practices . . . to distribute,
dispense, [or] administer . . . a
controlled substance in the course of
professional practice.’’ 21 U.S.C.
§ 802(21). Second, in setting the
requirements for obtaining a
practitioner’s registration, Congress
directed that ‘‘[t]he Attorney General
shall register practitioners . . . if the
applicant is authorized to dispense . . .
controlled substances under the laws of
the State in which he practices.’’ 21
U.S.C. § 823(f).
Because Congress has clearly
mandated that a practitioner possess
state authority in order to be deemed a
practitioner under the Act, DEA has
held repeatedly that revocation of a
practitioner’s registration is the
appropriate sanction whenever he is no
longer authorized to dispense controlled
substances under the laws of the State
in which he engages in professional
practice. See, e.g., Calvin Ramsey, 76 FR
20034, 20036 (2011); Sheran Arden
Yeates, M.D., 71 FR 39130, 39131
(2006); Dominick A. Ricci, 58 FR 51104,
51105 (1993); Bobby Watts, 53 FR
11919, 11920 (1988); Blanton, 43 FR at
27617.
Accordingly, because Registrant
currently lacks authority to dispense
controlled substances in Arkansas, the
State in which he holds his DEA
registration, I will order that his
registration be revoked.
Order
Pursuant to the authority vested in me
by 21 U.S.C. §§ 823(f) and 824(a)(3), as
well as 28 CFR 0.100(b), I order that
DEA Certificate of Registration
FL2413297 issued to Donald W.
Lamoureaux, M.D., be, and it hereby is,
revoked. I further order that any
pending application of Donald W.
Lamoureaux, M.D., to renew or modify
his registration, be, and it hereby is,
denied. This Order is effective February
24, 2017.
VerDate Sep<11>2014
20:29 Jan 24, 2017
Jkt 241001
Dated: January 17, 2017.
Chuck Rosenberg,
Acting Administrator.
[FR Doc. 2017–01688 Filed 1–24–17; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the System Unit
Resource Protection Act
On January 19, 2017, the Department
of Justice lodged a proposed consent
decree with the United States District
Court for the Northern District of
California in United States v. Tomales
Bay Oyster Company, LLC, Civil Action
No. 3:17–cv–00255.
The United States filed a complaint
under the System Unit Resource
Protection Act, 54 U.S.C. 100722(a), and
California trespass law seeking damages
and response costs stemming from the
Defendant’s alleged use of a parcel of
land owned by the United States and
administered by the United States
National Park Service as part of the
Golden Gate National Recreation Area.
The United States simultaneously
lodged a consent decree which would
settle these claims in return for a
payment of $280,000. From this sum,
the Department of Justice will deposit
$267,742 in the Department of the
Interior’s Natural Resource Damage
Assessment and Restoration Fund to
pay for response and natural resource
damage assessment costs incurred by
the United States and natural resource
restoration projects related to this
incident. The Department of Justice will
deposit the remaining $12,258 in the
United States Treasury.
The publication of this notice opens
a period for public comment on the
proposed consent decree. Comments
should be addressed to the Assistant
Attorney General, Environment and
Natural Resources Division, and should
refer to United States v. Tomales Bay
Oyster Company, LLC, D.J. Ref. No. 90–
5–1–1–11544. All comments must be
submitted no later than thirty (30) days
after the publication date of this notice.
Comments may be submitted either by
email or by mail:
To submit
comments:
Send them to:
By email .......
pubcomment-ees.enrd@
usdoj.gov.
Assistant Attorney General,
U.S. DOJ—ENRD, P.O.
Box 7611, Washington, DC
20044–7611.
By mail .........
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
8435
During the public comment period,
the proposed consent decree may be
examined and downloaded at this
Justice Department Web site: https://
www.justice.gov/enrd/consent-decrees.
We will provide a paper copy of the
proposed consent decree upon written
request and payment of reproduction
costs. Please mail your request and
payment to: Consent Decree Library,
U.S. DOJ—ENRD, P.O. Box 7611,
Washington, DC 20044–7611.
Please enclose a check or money order
for $4.75 (25 cents per page
reproduction cost) payable to the United
States Treasury.
Henry Friedman,
Assistant Section Chief, Environmental
Enforcement Section, Environment and
Natural Resources Division.
[FR Doc. 2017–01698 Filed 1–24–17; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Notice of Lodging of Proposed
Consent Decree Under the Clean Water
Act
On January 17, 2017, the Department
of Justice lodged a proposed Consent
Decree with the United States District
Court for the Eastern District of Texas in
the lawsuit entitled United States and
the State of Texas v. City of Tyler,
Texas, Civil Action No. 6:17–cv–00029.
The United States of America and the
State of Texas (collectively, ‘‘Plaintiffs’’)
filed a complaint against the City of
Tyler, Texas, (‘‘Defendant’’) alleging that
Defendant violated and continues to
violate Section 301 of the Clean Water
Act (‘‘CWA’’), 33 U.S.C. 1311, and
Section 26.121(a)(1) of the Texas Water
Code (‘‘TWC’’) by discharging raw
sewage from the City of Tyler’s
wastewater collection and treatment
systems (‘‘WCTS’’) into or adjacent to
local waterways. The complaint further
alleges that Defendant failed to comply
with the terms and conditions of its two
Texas Pollutant Discharge Elimination
System permits, issued pursuant to
Section 402 of the CWA, 33 U.S.C. 1342,
and in violation of Section 7.101 of the
TWC, due to operational failures,
Defendant’s failure to issue all necessary
reports required by its permits, and
Defendant’s failure to adequately
safeguard against discharges during
power outages. The complaint alleges
violations have been ongoing since
2005. The Plaintiffs seek injunctive
relief, pursuant to Section 309(b) of the
CWA, 33 U.S.C. 1319(b), and Section
7.032 of the TWC, and civil penalties,
pursuant to Section 309(d) of the CWA,
E:\FR\FM\25JAN1.SGM
25JAN1
Agencies
[Federal Register Volume 82, Number 15 (Wednesday, January 25, 2017)]
[Notices]
[Pages 8434-8435]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-01688]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Donald W. Lamoureaux, M.D.; Decision and Order
On September 16, 2016, the Assistant Administrator, Division of
Diversion Control, Drug Enforcement Administration (DEA), issued an
Order to Show Cause to Donald W. Lamoureaux, M.D. (Registrant), of
Horseshoe Bend, Arkansas. The Show Cause Order proposed the revocation
of his DEA Certificate of Registration, pursuant to which he is
authorized to dispense controlled substances in schedules II through V,
as a practitioner, on the ground that he ``do[es] not have authority to
handle controlled substances in Arkansas, the [S]tate in which he is
registered with the DEA.'' Show Cause Order, at 1.
As grounds for the proceeding, the Show Cause Order alleged that
Registrant is registered with the DEA as a practitioner authorized to
dispense controlled substances in schedules II through V, pursuant to
Certificate of Registration No. FL2413297, at the registered address of
707 Third Street, Horseshoe Bend, Arkansas. Id. The Order also alleged
that his registration does not expire until March 31, 2017. Id.
The Show Cause Order then alleged that Registrant's Arkansas
medical license expired on April 30, 2015, and that he is currently
without authority to dispense controlled substances in Arkansas, the
State in which he is registered with the DEA. Id. at 1-2. Based upon
Registrant's lack of authority to handle controlled substances in the
State of Arkansas, the Government asserts that his registration is
subject to revocation. Id. at 2 (citing 21 U.S.C. Sec. Sec. 802(21),
823(f) and 824(a)(3)).
The Show Cause Order also notified Registrant of his right to
request a hearing on the allegations or to submit a written statement
in lieu of a hearing, the procedures for electing either option, and
the consequence for failing to elect either option. Id. at 2 (citing 21
CFR 1301.43). In addition, the Order notified Registrant of his right
to submit a Corrective Action Plan. Id. at 2-3.
On September 19, 2016, the Show Cause Order was sent via certified
mail to Registrant at his current residence, the Federal Correctional
Institution, Butner, North Carolina, 27509. Government Request for
Final Agency Action (RFAA), Appendix 4, Declaration, at 1. As evidenced
by a copy of the signed return receipt card, service was accomplished
on September 22, 2016. Id.; See also Appendix 4, at 3-4.
On November 1, 2016, the Government forwarded to my Office a
Request for Final Agency Action and an evidentiary record. In its
Request, the Government represents that it has not received a request
for a hearing or any other reply from Registrant. RFAA, at 2. The
Government thus seeks the revocation of Registrant's Registration on
the ground that he lacks state authority. Id. at 4.
Based upon the Government's representation and the record, I find
that more than 30 days have now passed since the date of service of the
Show Cause Order, and neither Registrant, nor anyone purporting to
represent him, has requested a hearing or submitted a written statement
in lieu of a hearing. I therefore find that Registrant has waived his
right to a hearing or to submit a written statement in lieu of a
hearing and issue this Decision and Final Order based on relevant
evidence contained in the record submitted by the Government. 21 CFR
1301.43(d) & (e). I make the following findings of fact.
Findings
Respondent is the holder of practitioner's registration FL2413297,
pursuant to which he is authorized to dispense controlled substances in
schedules II through V at the registered address of 707 Third Street,
Horseshoe Bend, Arkansas; this registration does not expire until March
31, 2017. Declaration of the Diversion Investigator (DI), at 1.
According to the DI, Registrant's license to practice medicine in
Arkansas lapsed on April 30, 2015, and he currently has no authority to
practice medicine in that State. Id. at 1.
As further support for the action, the DI obtained, and the
Government submitted, a license verification from the Arkansas State
Medical Board along with a Certification from the Board's Executive
Secretary that the license verification was true and correct as of
September 15, 2016. Appendix 2, at 1; Appendix 3, at 1. This document
shows that as of September 14, 2016, the Board listed the expiration
date of Registrant's medical license as ``April 30, 2015'' and the
status of his license as ``Inactive''; it also includes the notation:
``License Category: Felony Conviction.'' Appendix 3, at 2. Also, the
document contains the following Board History notes, which include
that:
1. On February 9, 2015, the Board issued an Emergency Order of
Suspension to Registrant;
2. On April 10, 2015, the Board voted ``to continue the
disciplinary hearing until after [Registrant's] [] trial date'';
3. On July 2, 2015, the Board voted ``to block [Registrant's]
access to renew his license should he wish to renew''; and
4. On December 3, 2015, Registrant's ``medical license lapsed
subsequent to the felony criminal conviction.''
Appendix 3, at 4-5. As Registrant did not respond to the Show Cause
Order, let alone submit any evidence to show that his state license has
been reinstated, I find that he does not possess authority to dispense
controlled substances under the laws of Arkansas, the State in which he
is registered with the Agency.
Discussion
Pursuant to 21 U.S.C. 824(a)(3), the Attorney General is authorized
to suspend or revoke a registration issued under section 823 of Title
21, ``upon a finding that the registrant . . . has had his State
license . . . suspended [or] revoked . . . by competent State authority
and is no longer authorized by State law to engage in the . . .
dispensing of controlled substances.'' With respect to a practitioner,
DEA has repeatedly held that the possession of authority to dispense
controlled
[[Page 8435]]
substances under the laws of the State in which he engages in
professional practice is a fundamental condition for obtaining and
maintaining a registration. See, e.g., James L. Hooper, 76 FR 71371
(2011), pet. for rev. denied, 481 Fed Appx. 826 (4th Cir. 2012); see
also Frederick Marsh Blanton, 43 FR 27616 (1978) (``State authorization
to dispense or otherwise handle controlled substances is a prerequisite
to the issuance and maintenance of a Federal controlled substances
registration.'').
This rule derives from the text of two provisions of the CSA.
First, Congress defined ``the term `practitioner' [to] mean[] a . . .
physician . . . or other person licensed, registered, or otherwise
permitted, by . . . the jurisdiction in which he practices . . . to
distribute, dispense, [or] administer . . . a controlled substance in
the course of professional practice.'' 21 U.S.C. Sec. 802(21). Second,
in setting the requirements for obtaining a practitioner's
registration, Congress directed that ``[t]he Attorney General shall
register practitioners . . . if the applicant is authorized to dispense
. . . controlled substances under the laws of the State in which he
practices.'' 21 U.S.C. Sec. 823(f).
Because Congress has clearly mandated that a practitioner possess
state authority in order to be deemed a practitioner under the Act, DEA
has held repeatedly that revocation of a practitioner's registration is
the appropriate sanction whenever he is no longer authorized to
dispense controlled substances under the laws of the State in which he
engages in professional practice. See, e.g., Calvin Ramsey, 76 FR
20034, 20036 (2011); Sheran Arden Yeates, M.D., 71 FR 39130, 39131
(2006); Dominick A. Ricci, 58 FR 51104, 51105 (1993); Bobby Watts, 53
FR 11919, 11920 (1988); Blanton, 43 FR at 27617.
Accordingly, because Registrant currently lacks authority to
dispense controlled substances in Arkansas, the State in which he holds
his DEA registration, I will order that his registration be revoked.
Order
Pursuant to the authority vested in me by 21 U.S.C. Sec. Sec.
823(f) and 824(a)(3), as well as 28 CFR 0.100(b), I order that DEA
Certificate of Registration FL2413297 issued to Donald W. Lamoureaux,
M.D., be, and it hereby is, revoked. I further order that any pending
application of Donald W. Lamoureaux, M.D., to renew or modify his
registration, be, and it hereby is, denied. This Order is effective
February 24, 2017.
Dated: January 17, 2017.
Chuck Rosenberg,
Acting Administrator.
[FR Doc. 2017-01688 Filed 1-24-17; 8:45 am]
BILLING CODE 4410-09-P